Compare Ginkgo Bioworks Holdings Inc (DNA) vs Emerson Electric Co. (EMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs Emerson Electric Co. — how do they compare? Ginkgo Bioworks Holdings Inc trades at $13 (market cap $763.64M), while Emerson Electric Co. trades at $161.83 (market cap $88.72B). The key difference: Emerson Electric Co. is far larger — about 116.2× Ginkgo Bioworks Holdings Inc's market cap, and Emerson Electric Co. pays a 1.4% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ginkgo Bioworks Holdings Inc for 7 Days and Emerson Electric Co. for 81 Days on average.
| DNA | EMR | |
|---|---|---|
Market Cap | $763.64M | $88.72B |
Volume | 3,204,177 | 2,355,255 |
Sector | Health | Industrials |
52-Week High | $15.83 | $164.38 |
52-Week Low | $5.48 | $123.30 |
Typical Hold Time | 7 Days | 81 Days |
Enterprise Value | $865.59M | $99.80B |
Dividend Yield | — | 1.4% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ginkgo Bioworks (DNA) trades at $11.34, down 1.13% on the day, with a bullish technical signal from moving averages. The company reported a net loss of $312.76 million on $170.16 million revenue for 2025, with negative cash flow. Recent news includes a $17.5 million ARPA-H subcontract for RNA medicine manufacturing, highlighting ongoing strategic initiatives despite financial challenges.
The outlook remains speculative given persistent losses and cash burn, though analyst consensus is divided. Key risks include execution on revenue growth and path to profitability. Upside depends on successful commercialization of its biotech platform and partnerships, but high volatility and fundamental weakness warrant caution for investors.
Emerson Electric (EMR) trades at $159.06, down slightly by 0.1% today, with a bullish technical signal from moving averages and a consensus price target of $165.90. The company has beaten earnings estimates for the last three quarters, with Q3 2026 EPS expected at $1.84. Revenue grew to $18.02B in 2025, and net income margin improved to 13.83%, supported by strong cash flow from operations of $3.10B.
EMR presents a favorable outlook with analyst buy ratings at 53.49% and projected revenue growth to $18.6B in 2026. Risks include elevated valuation ratios like a P/E of 34.81 and debt-to-asset ratio increase to 31.26 in 2025. The stock's upside is tied to continued earnings beats and operational execution amid industrial sector competition.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About Emerson Electric Co.
Emerson Electric is a multi-industrial conglomerate that operates under two business platforms: automation solutions and commercial and residential solutions. The latter is further subdivided into two operating segments: climate technologies, which sells HVAC and refrigeration products and services as well as tools and home products, which sells tools and compressors, among other products and services. Commercial and residential solutions boasts several household brands, including Copeland and RIDGID. Automation solutions is most known for its process manufacturing solutions, which consists of measurement instrumentation, as well as valves and actuators, among other products and services. Roughly half of the firm's geographic sales take place in the United States.
Read more on EMR →
